Pfiz­er clin­i­cal tri­al reg­istry aims to re­cruit one mil­lion peo­ple for re­search

Pfiz­er is look­ing to en­roll one mil­lion peo­ple for its new clin­i­cal tri­al reg­istry called Pfiz­er­Link. The bio­phar­ma is ad­ver­tis­ing the clin­i­cal tri­al con­nec­tor on so­cial me­dia and on­line, invit­ing both healthy vol­un­teers and peo­ple with med­ical con­di­tions to sign up for the ser­vice.

Dur­ing the sign-up process, po­ten­tial par­tic­i­pants share some health de­tails, and then Pfiz­er­Link will match them to ap­pro­pri­ate cur­rent — or fu­ture — Pfiz­er clin­i­cal tri­als and will al­so help par­tic­i­pants take the next step to con­nect to lo­cal study doc­tors.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER